IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Q3 2023 Holdings

Filed 2023-11-13 | 15 holdings | $645.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Disc Medicine, Inc.(IRON)Common Stock254604101$129.0M2,745,33520.0%
Day One Biopharmaceuticals, Inc.(DAWN)Common Stock23954D109$93.4M7,608,39414.5%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$88.6M9,885,44913.7%
Kymera Therapeutics, Inc.(KYMR)Common Stock501575104$81.4M5,858,26212.6%
Third Harmonic Bio, Inc.(THRD)Common Stock88427A107$69.7M10,907,85910.8%
Replimune Group, Inc.(REPL)Common Stock76029N106$35.9M2,098,3005.6%
Vigil Neuroscience, Inc.(VIGL)Common Stock92673K108$31.5M5,836,8744.9%
Generation Bio, Co.(GBIOGBX)Common Stock37148K100$31.4M8,279,4844.9%
Aerovate Therapeutics, Inc.Common Stock008064107$27.7M2,039,2494.3%
Ikena Oncology, Inc.Common Stock45175G108$21.7M5,018,1783.4%
Akero Therapeutics, Inc.(AKRO)Common Stock00973Y108$18.2M359,2512.8%
AvroBio, Inc.Common Stock05455M100$7.0M4,541,3811.1%
Xilio Therapeutics, Inc.(XLO)Common Stock98422T100$5.8M2,759,3440.9%
Dianthus Therapeutics, Inc.(DNTH)Common Stock252828108$3.2M236,9790.5%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$1.2M1,013,4380.2%